Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
BioHarvest Sciences Invests US$5.5 million (₪20.2 million) to Open New Facility in Yavne, Israel
BioHarvest Sciences plans to invest US$55 million to open new campus for botanical synthesis CDMO and expansion of manufacturing capacity in Yavne, Israel
Ardena Invests US$25 million (€20 million) to Expand New Facility in Belgium, Europe
Ardena plans to invest US$25 million 20 million to expand its new analytical laboratories in its expanded nanomedicines facility The addition of the new 2,200m2 space, strategically positioned adjacent to current 4,000 square
Merck Invests US$354 million (€300 million) to Open Science Research Centre in Germany
Merck invests US$354 million 300 million to open new life science research centre in Germany The advanced research centre focuses on conducting research into manufacturing antibodies,
TriLink BioTechnologies to Open Drug Production Facility in USA
TriLink BioTechnologies plans to open a stateoftheart facility dedicated to latephase mRNA drug substance production in the United States
Fujifilm Invests US$1.2 billion to Expand Manufacturing Facility in USA
Fujifilm plans to invest US$12 billion to open stateoftheart manufacturing hubs in the United States The expansion will significantly enhance the largescale production
Almac Group Invests US$540 million (£400mn) to Expand Production Capacity in Ireland
Almac Group invests US$540 million 400mn for the completion of two new purposebuilt facilities at Ireland
Sandoz Plans to Open New Production Facility in Austria, Europe
Sandoz plans to open a new antibiotic production facility in Austria, Europe This stateoftheart facility will boost the production capacity for crucial lifesaving medicines
Novartis Invests US$541 million (€500 million) in Austria, Europe
Novartis is investing US$541 million 500 million to open new biopharmaceutical production in Austria To enhance production capabilities through innovative initiatives
Abzena Invests US$5 million to Expands its Manufacturing Site in Pennsylvania, USA
Abzena invests US$5 million to expand its bioconjugate development and cGMP manufacturing site in Pennsylvania, USA The investment in expanding laboratory space, acquiring new equipment
Syngene Biologics Invests US$98 million for Upgrading Manufacturing Facility in India
Syngene Biologics plans to invest US$98 million to open newly upgraded biologics facility in Bangalore, India The new facility with two production suites, each housing with 2KL
